Agomab Therapeutics director David R. Epstein reports $88,679.20 share purchase
AGMB•Agomab Therapeutics director David R. Epstein purchased 14,980 common shares for $88,679.20, at prices ranging from $5.75 to $6.02 per share. His direct beneficial ownership rose to 54,980 shares.
1. Share purchase
David R. Epstein purchased 14,980 Agomab Therapeutics common shares at prices ranging from $5.75 to $6.02 per share. His direct beneficial ownership rose to 54,980 common shares.




